dabigatran has been researched along with Coagulation Disorders, Blood in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (5.00) | 29.6817 |
2010's | 17 (85.00) | 24.3611 |
2020's | 2 (10.00) | 2.80 |
Authors | Studies |
---|---|
Nalezinski, S | 1 |
Chen, H; Gu, H; Hu, L; Lin, X; Liu, H; Xu, Z; Yang, X | 1 |
Manolopoulos, VG; Ragia, G | 1 |
Birschmann, I; Blumenstock, G; Ebner, M; Härtig, F; Kuhn, J; Peter, A; Poli, S; Spencer, C; Ziemann, U; Zuern, CS | 1 |
Levy, JH; Neal, MD | 1 |
Faul, O; Gehring, FK; Hussain, M; Körber, MK; Langer, E; Northoff, H; Schmidt, K; von Heymann, C; Wendel, HP | 1 |
Binet, Q; Hermans, C; Lambert, C | 1 |
Gan, G; Grottke, O; Honickel, M; Rossaint, R; Spronk, HMH; Ten Cate, H; van Ryn, J; Zentai, C | 1 |
Bachellerie, B; Conil, JM; Crognier, L; Fourcade, O; Georges, B; Ruiz, S; Seguin, T | 1 |
Debasse, M; Jacquemin, M; Peerlinck, K; Peetermans, M; Schoeters, J; Toelen, J; van Horenbeeck, I; van Ryn, J; Vanassche, T; Vanlinthout, I; Verhamme, P | 1 |
Ansell, JE | 1 |
Ali, JT; Ali, S; Aydelotte, JD; Brown, CV; Coopwood, TB; Daley, MJ; Enright, Z; Nguyen, J; Teixeira, PG; Vadiei, N | 1 |
Heindl, B; Spannagl, M | 1 |
Mousa, SA | 1 |
Asakura, H | 1 |
Alpert, JS | 1 |
Brouns, R; De Keyser, J; De Raedt, S; De Smedt, A; Jochmans, K; Luijckx, GJ; Moens, M; Uyttenboogaart, M; Van Hooff, RJ | 1 |
Arnold, DM; Crowther, MA; Eltringham-Smith, LJ; Gataiance, S; Lambourne, MD; Sheffield, WP | 1 |
Curnow, J; Dunkley, S; Kershaw, G; Khoo, TL; Reddel, CJ; Weatherburn, C | 1 |
Chance, EA; Huang, GS | 1 |
5 review(s) available for dabigatran and Coagulation Disorders, Blood
Article | Year |
---|---|
Methods to Correct Drug-Induced Coagulopathy in Bleeding Emergencies: A Comparative Review.
Topics: Anticoagulants; Blood Coagulation Disorders; Dabigatran; Emergencies; Hemorrhage; Humans; Vitamin K | 2022 |
Reversing the Effect of Oral Anticoagulant Drugs: Established and Newer Options.
Topics: Administration, Oral; Animals; Antibodies, Monoclonal, Humanized; Anticoagulants; Antifibrinolytic Agents; Antithrombins; Arginine; Blood Coagulation Disorders; Blood Coagulation Factors; Coagulants; Combined Modality Therapy; Dabigatran; Drugs, Investigational; Enoxaparin; Factor Xa; Fibrinolytic Agents; Humans; Piperazines; Practice Guidelines as Topic; Recombinant Proteins; Vitamin K | 2016 |
[New oral anticoagulants. Consequences for perioperative coagulation diagnostics and therapy].
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; Blood Coagulation Disorders; Dabigatran; Factor Xa Inhibitors; Humans; International Normalized Ratio; Intraoperative Complications; Morpholines; Partial Thromboplastin Time; Pyridines; Rivaroxaban; Thiophenes; Thrombin; Thromboembolism | 2009 |
[Interpretation of hemostatic and fibrinolytic markers].
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Dabigatran; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Partial Thromboplastin Time; Plasminogen Activators; Prothrombin Time; Thrombomodulin; Warfarin | 2011 |
Acute stroke management in patients taking dabigatran.
Topics: Anticoagulants; Benzimidazoles; Blood Coagulation Disorders; Case Management; Cerebral Hemorrhage; Cerebral Infarction; Dabigatran; Guidelines as Topic; Hemostasis; Hemostatics; Humans; Off-Label Use; Pyridines; Renal Dialysis; Reperfusion; Stroke; Vitamin K | 2012 |
15 other study(ies) available for dabigatran and Coagulation Disorders, Blood
Article | Year |
---|---|
Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations.
Topics: Adult; Anticoagulants; Blood Coagulation Disorders; Child; Dabigatran; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolytic Agents; Humans; Pain; Retrospective Studies; Vascular Malformations | 2023 |
Pharmacogenomics of anticoagulation therapy: the last 10 years.
Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; Dabigatran; Humans; Pharmacogenetics; Warfarin | 2019 |
Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions.
Topics: Aged; Aged, 80 and over; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Tests; Dabigatran; Emergencies; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Partial Thromboplastin Time; Point-of-Care Testing; Prothrombin Time; Pyrazoles; Pyridones; Rivaroxaban; Sensitivity and Specificity; Stroke; Thrombin Time; Thrombolytic Therapy | 2017 |
Precision Correction of Coagulopathy or Prothrombin Complex Concentrates?: Reversal Options for Dabigatran following Trauma.
Topics: Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Factors; Dabigatran; Humans | 2017 |
QCM-D surpassing clinical standard for the dose administration of new oral anticoagulant in the patient of coagulation disorders.
Topics: Biosensing Techniques; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Tests; Dabigatran; Factor V; Factor Xa; Female; Humans; Male; Partial Thromboplastin Time; Quartz Crystal Microbalance Techniques; Thrombin | 2018 |
Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformations.
Topics: Adult; Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Tests; Dabigatran; Female; Humans; Vascular Malformations; Young Adult | 2018 |
Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Blood Coagulation Disorders; Blood Volume; Dabigatran; Hemodilution; Male; Models, Animal; Plasma Substitutes; Sus scrofa | 2019 |
[Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].
Topics: Acute Kidney Injury; Aged, 80 and over; Alzheimer Disease; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Dabigatran; Diabetes Mellitus, Type 2; Drug Overdose; Hemorrhage; Humans; Hyperkalemia; Male; Neoplasms; Phlebitis; Renal Dialysis | 2014 |
The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders.
Topics: Activated Protein C Resistance; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antibody Specificity; Antithrombins; Blood Coagulation Disorders; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Immunologic; False Negative Reactions; False Positive Reactions; Hemophilia A; Humans; Lupus Coagulation Inhibitor | 2015 |
Thromboelastogram does not detect pre-injury anticoagulation in acute trauma patients.
Topics: Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation Disorders; Case-Control Studies; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Humans; International Normalized Ratio; Male; Middle Aged; Partial Thromboplastin Time; Retrospective Studies; Thrombelastography; Warfarin; Wounds, Nonpenetrating | 2017 |
The future of anticoagulant therapy.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Dabigatran; Drug Approval; Fibrinolytic Agents; Humans; Morpholines; Rivaroxaban; Stroke; Thiophenes | 2012 |
New directions in anticoagulation.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin | 2012 |
Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate.
Topics: Animals; Anticoagulants; Antithrombin Proteins; Benzimidazoles; Blood Coagulation Disorders; Dabigatran; Mice; Prothrombin; Pyridines; Warfarin | 2012 |
The use of FEIBA® in the correction of coagulation abnormalities induced by dabigatran.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Disorders; Blood Coagulation Factors; Clinical Chemistry Tests; Dabigatran; Humans; Research Design | 2013 |
When dabigatran and trauma collide.
Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Dabigatran; Fatal Outcome; Female; Hemorrhage; Humans; Male; Middle Aged; Wounds and Injuries | 2013 |